Skip to Main Content

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation (APOLLO)

Conditions

Diseases of the Cardiovascular System

What is the purpose of this trial?

Multi-center, global, prospective, randomized, interventional, pre-market trial with two subject groups: the randomized group will be randomized on 1:1 basis to either the study device or to conventional mitral valve surgery. Subjects in the single-arm group will receive the study device.

Subjects will be seen at pre- and post-procedure, discharge, 30 days, 6 months, and annually through 5 years.

  • Trial with
    Medtronic, Inc
  • Start Date
    03/04/2018
  • End Date
    10/30/2021
Trial Image

For more information about this study, contact:

Sarah McManus

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    01/17/2019
  • Study HIC
    #2000021883